Analysis of publicly available expression array data from TSC2-null AML-derived cells (51) revealed that DEGS1 and ASAH1 transcripts were significantly increased in TSC2-null AML-derived cells, compared with TSC2-reexpressing cells. This evidence concerns the gene TSC2 and acute myeloid leukemia.